Assyro AI

FDA Orange Book · active-ingredient family

Ertugliflozin; metformin hydrochloride

Ertugliflozin; metformin hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:SEGLUROMET · NDA 209806

1

Brand (NDA)

0

Generics (ANDA)

3

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
SEGLUROMETRLD×4MSD SUB MERCKNDA 209806Dec 19, 2017

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9439902Oct 21, 2030in 4 yr 5 mo
U-2214
9308204Oct 21, 2030in 4 yr 5 mo
Product
8080580Dec 19, 2031in 5 yr 7 mo
SubstanceProductU-2214

Ertugliflozin; metformin hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.